Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
Year: 2013
How to make a representation to the EPA about the proposed Deliberate Release G0493
Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine
Waste Management Policy in Ireland, April 2013
Year: 2013
This policy document sets out the measure through which Ireland will make the further pogress necessary to become a recycling society, with a clear focus on resource efficiency and the virtual elimination of landfilling of municipal waste. This is a Department of Environment, Community and Local Government publication.
Year: 2013
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency
Year: 2013
An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed
Year: 2013
Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01
Year: 2013
Summary Notification Information Format for proposed Clinical Trial G0498-01
Year: 2013
Environmental Risk Assessment Dossier for Clinical Trial G0498-01
Year: 2013
Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01
Year: 2013
The GMO Register entry provides significant details of the clinical trial
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received.
Year: 2013
G0498-01 Consent Condition issued to The Centre for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, USA, on 3 July 2013 for a clinical trial using a Genetically Modified Organism (GMO) at St. James's Hospital Dublin
Year: 2013
Environmental Objectives Regulations (EO Regs) Review Form
Year: 2013
The purpose of this circular is to briefly outline the main provisions of the Urban Waste Water Treatment Regulations 1994, and the implications for Sanitary Authorities.
Year: 2013
The purpose of this Circular letter is to provide Local Authorities with basic guidance on identifying potential issues relating to protection of natural heritage (including sites, habitats and species) and archaeological heritage.
Abstraction Points Template, January 2013
Year: 2013
Detailed information is required to enable the Agency to assess the existing receiving environment. This section requires the provision of information on the ambient environmental conditions within the receiving water(s) upstream and downstream of any discharge(s).
Year: 2013
This guidance note has been prepated to assist applicants in submitting electronic information on facility location
Year: 2013
This form is for the purpose of making an application for a Waste Water Discharge Licence under the Waste Water Discharge (Authorisation) Regulations 2007 as amended or for the review of an existing Waste Water Discharge Licence.